Lawsuit Overview
August 29, 2014 (Shareholders Foundation) - An investor, who currently holds shares of InterMune Inc (NASDAQ:ITMN) filed a lawsuit in effort to halt the proposed takeover of InterMune Inc by Roche for $74.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:ITMN stockholders by agreeing to sell InterMune Inc too cheaply via an unfair ...
You must register (for free) or login to view the entire case.